The role of nanobiotechnology in drug discovery.
The potential applications of nanotechnology in life sciences, particularly nanobiotechnology, include those for drug discovery. This chapter shows how several of the nanotechnologies including nanoparticles and various nanodevices such as nanobiosensors and nanobiochips are being used to improve drug discovery. Nanoscale assays using nanoliter volumes contribute to cost saving. Some nanosubstances such as fullerenes are drug candidates. There are some safety concerns about the in vivo use of nanoparticles that are being investigated. However, future prospects for applications in healthcare of drugs discovered through nanotechnology and their role in the development of personalized medicine appear to be excellent.
Jain
Kewal K
KK
Jain PharmaBiotech, Blaesiring 7, CH-4057, Basel, Switzerland. jain@pharmabiotech.ch
D015374:Biosensing Techniques; D001709:Biotechnology / Q000379:methods*; D015195:Drug Design; D055808:Drug Discovery; D037741:Fullerenes / Q000737:chemistry; D006801:Humans; D018625:Microscopy, Atomic Force / Q000379:methods; D053758:Nanoparticles / Q000737:chemistry; D049329:Nanostructures / Q000737:chemistry; D036103:Nanotechnology / Q000379:methods*; D037742:Nanotubes, Carbon / Q000737:chemistry; D045663:Quantum Dots
D037741:Fullerenes; D037742:Nanotubes, Carbon